ATIEH MICHAEL G
Insider CIK 1072501 · OPHT EVP,CFO & CBO, Treasurer · ECOR Director · TBPH Director · OYST Director · IMTX Director · ACE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMTX Immatics N.V. | A Award deriv | 2026-06-16 | 2026-06-18 | 48,000 | — | $0 | 48,000 | SEC↗ |
| CB Chubb Ltd | A Award | 2026-05-21 | 2026-05-26 | 681 | — | $0 | 40,785 | SEC↗ |
| CB Chubb Ltd | F Tax w/h | 2026-05-21 | 2026-05-26 | 193 | $330.26 | $63.7K | 40,592 | SEC↗ |
| CB Chubb Ltd | S Sale | 2026-05-21 | 2026-05-26 | 578 | $329.53 | $190.5K | 40,014 | SEC↗ |
| CB Chubb Ltd | S Sale | 2025-06-16 | 2025-06-18 | 538 | $287.56 | $154.7K | 39,474 | SEC↗ |
| CB Chubb Ltd | F Tax w/h | 2025-05-15 | 2025-05-16 | 180 | $292.05 | $52.6K | 40,012 | SEC↗ |
| CB Chubb Ltd | A Award | 2025-05-15 | 2025-05-16 | 771 | — | $0 | 40,192 | SEC↗ |
| CB Chubb Ltd | S Sale | 2024-09-03 | 2024-09-05 | 261 | $287.49 | $75.0K | 39,172 | SEC↗ |
| CB Chubb Ltd | S Sale | 2024-05-17 | 2024-05-20 | 716 | $269.70 | $193.1K | 39,295 | SEC↗ |
| CB Chubb Ltd | F Tax w/h | 2024-05-16 | 2024-05-17 | 239 | $264.88 | $63.3K | 40,011 | SEC↗ |
| CB Chubb Ltd | A Award | 2024-05-16 | 2024-05-17 | 718 | — | $0 | 40,250 | SEC↗ |
| CB Chubb Ltd | S Sale | 2023-07-28 | 2023-08-14 | 750 | $208.39 | $156.3K | 38,933 | SEC↗ |
| CB Chubb Ltd | F Tax w/h | 2023-05-17 | 2023-05-19 | 233 | $198.93 | $46.4K | 39,683 | SEC↗ |
| CB Chubb Ltd | A Award | 2023-05-17 | 2023-05-19 | 955 | — | $0 | 39,916 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | D To issuer deriv | 2023-01-03 | 2023-01-04 | 5,359 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | D To issuer deriv | 2023-01-03 | 2023-01-04 | 5,199 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | D To issuer | 2023-01-03 | 2023-01-04 | 8,671 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | U Tender | 2023-01-03 | 2023-01-04 | 18,063 | — | $0 | 8,671 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | A Award deriv | 2022-06-06 | 2022-06-08 | 5,359 | — | $0 | 5,359 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | A Award | 2022-06-06 | 2022-06-08 | 3,573 | — | $0 | 26,734 | SEC↗ |
| CB Chubb Ltd | S Sale | 2022-05-20 | 2022-05-23 | 500 | $203.49 | $101.7K | 38,340 | SEC↗ |
| CB Chubb Ltd | F Tax w/h | 2022-05-19 | 2022-05-23 | 271 | $203.88 | $55.3K | 38,840 | SEC↗ |
| CB Chubb Ltd | A Award | 2022-05-19 | 2022-05-23 | 932 | — | $0 | 39,111 | SEC↗ |
| CB Chubb Ltd | S Sale | 2021-08-18 | 2021-08-20 | 2,944 | $186.20 | $548.2K | 37,556 | SEC↗ |
| ECOR electroCore, Inc. | A Award deriv | 2021-06-11 | 2021-06-15 | 66,766 | — | $0 | 66,766 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | A Award deriv | 2021-06-07 | 2021-06-09 | 5,199 | — | $0 | 5,199 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | A Award | 2021-06-07 | 2021-06-09 | 3,466 | — | $0 | 23,161 | SEC↗ |
| CB Chubb Ltd | F Tax w/h | 2021-05-20 | 2021-05-24 | 431 | $166.16 | $71.6K | 40,500 | SEC↗ |
| CB Chubb Ltd | A Award | 2021-05-20 | 2021-05-24 | 1,083 | — | $0 | 40,931 | SEC↗ |
| CB Chubb Ltd | S Sale | 2021-02-10 | 2021-02-12 | 1,000 | $165.36 | $165.4K | 39,041 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | A Award | 2020-10-08 | 2020-10-13 | 15,295 | — | $0 | 15,295 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | A Award | 2020-10-08 | 2020-10-13 | 4,400 | — | $0 | 19,695 | SEC↗ |
| ECOR electroCore, Inc. | A Award deriv | 2020-06-12 | 2020-06-16 | 112,500 | — | $0 | 112,500 | SEC↗ |
| CB Chubb Ltd | A Award | 2020-05-20 | 2020-05-22 | 1,721 | — | $0 | 40,350 | SEC↗ |
| CB Chubb Ltd | F Tax w/h | 2020-05-20 | 2020-05-22 | 309 | $104.61 | $32.3K | 40,041 | SEC↗ |
| CB Chubb Ltd | S Sale | 2019-11-11 | 2019-11-13 | 1,500 | $151.12 | $226.7K | 38,232 | SEC↗ |
| ECOR electroCore, Inc. | A Award deriv | 2019-06-07 | 2019-06-11 | 63,291 | — | $0 | 63,291 | SEC↗ |
| CB Chubb Ltd | F Tax w/h | 2019-05-16 | 2019-05-20 | 316 | $145.62 | $46.0K | 39,387 | SEC↗ |
| CB Chubb Ltd | A Award | 2019-05-16 | 2019-05-20 | 1,236 | — | $0 | 39,703 | SEC↗ |
| CB Chubb Ltd | S Sale | 2019-05-09 | 2019-05-13 | 1,659 | $141.87 | $235.4K | 38,467 | SEC↗ |
| CB Chubb Ltd | S Sale | 2019-05-09 | 2019-05-13 | 341 | $141.86 | $48.4K | 0 | SEC↗ |
| CB Chubb Ltd | S Sale | 2018-11-28 | 2018-11-30 | 1,200 | $133.27 | $159.9K | 39,749 | SEC↗ |
| CB Chubb Ltd | S Sale | 2018-06-04 | 2018-06-06 | 920 | $130.86 | $120.4K | 40,561 | SEC↗ |
| CB Chubb Ltd | A Award | 2018-05-17 | 2018-05-21 | 1,264 | — | $0 | 41,134 | SEC↗ |
| CB Chubb Ltd | F Tax w/h | 2018-05-17 | 2018-05-21 | 307 | $134.45 | $41.3K | 41,481 | SEC↗ |
| CB Chubb Ltd | F Tax w/h | 2017-05-18 | 2017-05-22 | 321 | $138.56 | $44.5K | 39,870 | SEC↗ |
| CB Chubb Ltd | A Award | 2017-05-18 | 2017-05-22 | 1,227 | — | $0 | 39,847 | SEC↗ |
| CB Chubb Ltd | G Gift | 2016-11-11 | 2016-11-16 | 1,800 | — | $0 | 38,620 | SEC↗ |
| CB Chubb Ltd | A Award | 2016-05-19 | 2016-05-23 | 1,282 | — | $0 | 39,931 | SEC↗ |
| CB Chubb Ltd | F Tax w/h | 2016-05-19 | 2016-05-23 | 655 | $124.85 | $81.8K | 40,056 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2016-01-04 | 2016-01-05 | 23 | $74.05 | $1.7K | 299 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2016-01-04 | 2016-01-05 | 45 | $72.93 | $3.3K | 322 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2016-01-04 | 2016-01-05 | 34 | $71.15 | $2.4K | 391 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2016-01-04 | 2016-01-05 | 4 | $74.96 | $300 | 295 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2016-01-04 | 2016-01-05 | 24 | $71.93 | $1.7K | 367 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise deriv | 2016-01-02 | 2016-01-05 | 425 | — | $0 | 1,275 | SEC↗ |
| OPHT Ophthotech Corp. | M Exercise | 2016-01-02 | 2016-01-05 | 425 | — | $0 | 425 | SEC↗ |
| ACE ACE Ltd | A Award | 2015-05-21 | 2015-05-26 | 2,617 | — | $0 | 38,277 | SEC↗ |
| ACE ACE Ltd | F Tax w/h | 2015-05-21 | 2015-05-26 | 391 | $108.90 | $42.6K | 38,649 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2015-01-02 | 2015-01-06 | 1,700 | — | $0 | 1,700 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2015-01-02 | 2015-01-06 | 6,500 | — | $0 | 6,500 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2014-09-30 | 2014-10-03 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ACE ACE Ltd | S Sale | 2014-09-05 | 2014-09-09 | 5,000 | $105.95 | $529.8K | 35,660 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2014-06-03 | 2014-06-05 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TBPH Theravance Biopharma, Inc. | A Award deriv | 2014-06-03 | 2014-06-05 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ACE ACE Ltd | A Award | 2014-05-15 | 2014-05-19 | 1,564 | — | $0 | 40,306 | SEC↗ |
| ACE ACE Ltd | F Tax w/h | 2014-05-15 | 2014-05-19 | 380 | $102.29 | $38.9K | 40,660 | SEC↗ |
| ACE ACE Ltd | A Award | 2013-05-16 | 2013-05-20 | 1,520 | — | $0 | 38,858 | SEC↗ |
| ACE ACE Ltd | F Tax w/h | 2013-05-16 | 2013-05-20 | 465 | $92.11 | $42.8K | 38,742 | SEC↗ |
| ACE ACE Ltd | G Gift | 2012-11-01 | 2013-03-08 | 2,000 | — | $0 | 37,338 | SEC↗ |
| ACE ACE Ltd | G Gift | 2012-11-01 | 2013-03-08 | 2,000 | — | $0 | 341 | SEC↗ |
| ACE ACE Ltd | S Sale | 2012-11-01 | 2013-03-08 | 4,000 | $78.90 | $315.6K | 39,338 | SEC↗ |
| ACE ACE Ltd | M Exercise deriv | 2012-11-01 | 2012-11-05 | 4,000 | — | $0 | 0 | SEC↗ |
| ACE ACE Ltd | M Exercise | 2012-11-01 | 2012-11-05 | 4,000 | $34.45 | $137.8K | 43,715 | SEC↗ |
| ACE ACE Ltd | S Sale | 2012-11-01 | 2012-11-05 | 4,000 | $78.90 | $315.6K | 40,094 | SEC↗ |
| ACE ACE Ltd | G Gift | 2012-11-01 | 2012-11-05 | 2,000 | — | $0 | 38,094 | SEC↗ |
| ACE ACE Ltd | G Gift | 2012-11-01 | 2012-11-05 | 2,000 | — | $0 | 341 | SEC↗ |
| ACE ACE Ltd | F Tax w/h | 2012-05-16 | 2012-05-18 | 505 | $75.26 | $38.0K | 39,715 | SEC↗ |
| ACE ACE Ltd | A Award | 2012-05-16 | 2012-05-18 | 1,860 | — | $0 | 39,162 | SEC↗ |
| ACE ACE Ltd | M Exercise deriv | 2012-04-30 | 2012-05-01 | 4,000 | — | $0 | 0 | SEC↗ |
| ACE ACE Ltd | S Sale | 2012-04-30 | 2012-05-01 | 4,000 | $75.79 | $303.2K | 37,302 | SEC↗ |
| ACE ACE Ltd | M Exercise | 2012-04-30 | 2012-05-01 | 4,000 | $33.39 | $133.6K | 41,302 | SEC↗ |